Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$16.41
+1.9%
$13.10
$6.33
$18.23
$571.50M0.72373,751 shs793,178 shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$12.66
-28.4%
$12.77
$5.45
$18.98
$415.24M2.04154,954 shs1.79 million shs
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
$43.39
-2.1%
$36.08
$21.77
$81.56
$483.89M1.33495,373 shs1.08 million shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.97
-0.5%
$4.12
$0.52
$5.92
$261.31M1.92751,234 shs688,173 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
0.00%-10.99%+33.03%+13.05%+107.07%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
0.00%+4.00%+58.57%+27.75%+134.79%
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
0.00%+2.43%+20.30%+4.48%+90.05%
Neuronetics, Inc. stock logo
STIM
Neuronetics
0.00%-6.99%-10.94%-7.85%+83.03%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
3.3147 of 5 stars
3.54.00.00.03.92.50.6
NeuroPace, Inc. stock logo
NPCE
NeuroPace
1.6532 of 5 stars
1.43.00.00.03.44.20.6
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
2.505 of 5 stars
3.51.00.00.02.52.51.3
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.4019 of 5 stars
3.32.00.00.00.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
3.00
Buy$24.0046.25% Upside
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.80
Moderate Buy$15.0018.48% Upside
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
3.00
Buy$71.0063.63% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.67
Moderate Buy$5.5038.54% Upside

Current Analyst Ratings Breakdown

Latest STIM, NPCE, DCTH, and SMLR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/23/2025
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$24.00 ➝ $29.00
5/14/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$14.00 ➝ $16.00
5/14/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$17.00 ➝ $17.00
3/7/2025
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$22.00 ➝ $24.00
3/5/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$19.00 ➝ $20.00
3/5/2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$5.00 ➝ $8.00
(Data available from 5/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$53.85M10.61N/AN/A$0.72 per share22.79
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$84.31M4.93N/AN/A$0.79 per share16.03
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
$49.23M9.83$2.56 per share16.95$10.45 per share4.15
Neuronetics, Inc. stock logo
STIM
Neuronetics
$89.45M2.92N/AN/A$1.18 per share3.36
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$47.68M-$0.50N/AN/AN/A-150.70%-338.16%-104.02%8/4/2025 (Estimated)
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$32.96M-$0.84N/AN/AN/A-36.74%-205.41%-28.29%8/12/2025 (Estimated)
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
$20.58M-$2.618.84N/A72.65%50.77%47.04%8/4/2025 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$30.19M-$1.31N/AN/AN/A-50.09%-141.24%-32.77%8/11/2025 (Estimated)

Latest STIM, NPCE, DCTH, and SMLR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.26-$0.21+$0.05-$0.21$21.85 million$22.52 million
5/13/2025Q1 2025
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
N/A-$0.76N/A-$6.74N/A$8.84 million
5/8/2025Q1 2025
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$0.10$0.03-$0.07$0.03$16.83 million$19.80 million
5/6/2025Q1 2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.13-$0.21-$0.08-$0.21$29.07 million$31.98 million
3/6/2025Q4 2024
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.10-$0.11-$0.01-$0.11$14.96 million$15.10 million
3/4/2025Q4 2024
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.25-$0.18+$0.07-$0.18$21.14 million$21.47 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
N/AN/AN/AN/AN/A
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
1.34
1.03
NeuroPace, Inc. stock logo
NPCE
NeuroPace
6.03
5.59
4.77
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
N/A
3.14
3.09
Neuronetics, Inc. stock logo
STIM
Neuronetics
4.90
3.16
2.87

Institutional Ownership

CompanyInstitutional Ownership
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
78.83%
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
49.37%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%

Insider Ownership

CompanyInsider Ownership
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
17.40%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
22.20%
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
30.20%
Neuronetics, Inc. stock logo
STIM
Neuronetics
8.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
6034.83 million26.24 millionOptionable
NeuroPace, Inc. stock logo
NPCE
NeuroPace
17032.80 million23.22 millionOptionable
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
12011.15 million6.47 millionNot Optionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
18065.82 million27.37 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Delcath Systems stock logo

Delcath Systems NASDAQ:DCTH

$16.41 +0.30 (+1.86%)
Closing price 04:00 PM Eastern
Extended Trading
$16.41 0.00 (0.00%)
As of 04:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

NeuroPace stock logo

NeuroPace NASDAQ:NPCE

$12.66 -5.02 (-28.39%)
Closing price 04:00 PM Eastern
Extended Trading
$12.92 +0.27 (+2.09%)
As of 06:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Semler Scientific stock logo

Semler Scientific NASDAQ:SMLR

$43.39 -0.93 (-2.10%)
Closing price 04:00 PM Eastern
Extended Trading
$43.34 -0.05 (-0.10%)
As of 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$3.97 -0.02 (-0.50%)
Closing price 04:00 PM Eastern
Extended Trading
$4.05 +0.08 (+2.12%)
As of 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.